STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (STDAF) Given Average Recommendation of “Hold” by Brokerages

STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (NASDAQ:STDAF) has been given a consensus broker rating score of 3.00 (Hold) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a hold recommendation.

Zacks has also assigned STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) an industry rank of 148 out of 265 based on the ratings given to its competitors.

Several research analysts recently weighed in on STDAF shares. Zacks Investment Research cut shares of STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 15th. DZ Bank AG restated a “neutral” rating on shares of STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) in a research report on Monday, February 13th.

STADA ARZNEIMITTEL NP (NASDAQ:STDAF) remained flat at $71.80 during trading on Thursday. The stock’s 50 day moving average price is $71.72 and its 200 day moving average price is $59.88. STADA ARZNEIMITTEL NP has a 1-year low of $45.80 and a 1-year high of $73.87. The firm has a market cap of $4.47 billion and a P/E ratio of 38.07.

TRADEMARK VIOLATION NOTICE: “STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (STDAF) Given Average Recommendation of “Hold” by Brokerages” was reported by Stock Observer and is owned by of Stock Observer. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.thestockobserver.com/2017/06/20/stada-arzneimittel-npvregd-vinkuliert-stdaf-given-average-recommendation-of-hold-by-brokerages-updated.html.

Get a free copy of the Zacks research report on STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) (STDAF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STADA ARZNEIMITTEL NPV(REGD) (VINKULIERT) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply